TY - JOUR KW - Stem Cell Transplantation KW - Rifampicin KW - Ofloxacin KW - leprosy KW - Doxycycline KW - Autologous hematopoietic stem cell transplant (HSCT) AU - Salomão MC AU - Batista MV AU - Macedo MC AU - Sotto MN AU - Duarte AN AU - Rocha VG AU - Higashino HR AU - Costa SF AB -
A patient with non-Hodgkin lymphoma, preparing for an autologous hematopoietic stem cell transplant (HSCT), developed leprosy. The patient was successfully treated with rifampicin, ofloxacin, and doxycycline and the HSCT was performed without complications, being the first report, to our knowledge, of leprosy in an autologous HSCT patient.
BT - Transplant infectious disease : an official journal of the Transplantation Society C1 -http://www.ncbi.nlm.nih.gov/pubmed/29359841?dopt=Abstract
DO - 10.1111/tid.12840 J2 - Transpl Infect Dis LA - eng N2 -A patient with non-Hodgkin lymphoma, preparing for an autologous hematopoietic stem cell transplant (HSCT), developed leprosy. The patient was successfully treated with rifampicin, ofloxacin, and doxycycline and the HSCT was performed without complications, being the first report, to our knowledge, of leprosy in an autologous HSCT patient.
PY - 2018 T2 - Transplant infectious disease : an official journal of the Transplantation Society TI - Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe? SN - 1399-3062 ER -